{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T03:33:01Z","timestamp":1764646381539,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00417-022-05702-w","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T10:03:13Z","timestamp":1653472993000},"page":"3231-3239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of subretinal hemorrhage after treatment discontinuation for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy"],"prefix":"10.1007","volume":"260","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8121-6353","authenticated-orcid":false,"given":"Jae Hui","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul Gu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"5702_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ophtha.2007.03.008","volume":"115","author":"TY Wong","year":"2008","unstructured":"Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, Fahrbach K, Probst C, Sledge I (2008) The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 115:116\u2013126","journal-title":"Ophthalmology"},{"key":"5702_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/jamaophthalmol.2013.7647","volume":"132","author":"FA Sloan","year":"2014","unstructured":"Sloan FA, Hanrahan BW (2014) The effects of technological advances on outcomes for elderly persons with exudative age-related macular degeneration. JAMA Ophthalmol 132:456\u2013463","journal-title":"JAMA Ophthalmol"},{"key":"5702_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/aos.14183","volume":"98","author":"T Brynskov","year":"2020","unstructured":"Brynskov T, Munch IC, Larsen TM, Erngaard L, S\u00f8rensen TL (2020) Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration. Acta Ophthalmol 98:132\u2013138","journal-title":"Acta Ophthalmol"},{"issue":"725\u2013731","key":"5702_CR4","first-page":"e721","volume":"160","author":"JL Prenner","year":"2015","unstructured":"Prenner JL, Halperin LS, Rycroft C, Hogue S, Williams Liu Z, Seibert R (2015) Disease burden in the treatment of age-related macular degeneration: findings from a time-and-motion study. Am J Ophthalmol 160(725\u2013731):e721","journal-title":"Am J Ophthalmol"},{"key":"5702_CR5","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.ophtha.2019.04.018","volume":"126","author":"D Gong","year":"2019","unstructured":"Gong D, Chang JS, Barbany M, Corcostegui BF, Ka\u011fanDe\u011firmenci MF, Ishikawa H, Mammo Z, Ozmert E, Rossi T, Chang S (2019) Comparison of United States and international ophthalmic drug pricing. Ophthalmology 126:1358\u20131365","journal-title":"Ophthalmology"},{"key":"5702_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5301\/ejo.5001001","volume":"28","author":"S Doguizi","year":"2018","unstructured":"Doguizi S, Sekeroglu MA, Inanc M, Anayol MA, Yilmazbas P (2018) Evaluation of pain during intravitreal aflibercept injections. Eur J Ophthalmol 28:63\u201367","journal-title":"Eur J Ophthalmol"},{"issue":"89\u201395","key":"5702_CR7","first-page":"e83","volume":"155","author":"M Kr\u00fcger Falk","year":"2013","unstructured":"Kr\u00fcger Falk M, Kemp H, S\u00f8rensen TL (2013) Four-year treatment results of neovascular age-related macular degeneration with ranibizumab and causes for discontinuation of treatment. Am J Ophthalmol 155(89\u201395):e83","journal-title":"Am J Ophthalmol"},{"key":"5702_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/09286586.2017.1397701","volume":"25","author":"I Westborg","year":"2018","unstructured":"Westborg I, Rosso A (2018) Risk factors for discontinuation of treatment for neovascular age-related macular degeneration. Ophthalmic Epidemiol 25:176\u2013182","journal-title":"Ophthalmic Epidemiol"},{"key":"5702_CR9","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1097\/IAE.0000000000001494","volume":"37","author":"JH Kim","year":"2017","unstructured":"Kim JH, Chang YS, Kim JW (2017) Natural course of patients discontinuing treatment for age-related macular degeneration and factors associated with visual prognosis. Retina 37:2254\u20132261","journal-title":"Retina"},{"issue":"391\u2013398","key":"5702_CR10","first-page":"e395","volume":"122","author":"MM Altaweel","year":"2015","unstructured":"Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL 3rd, Fine SL, Maguire MG (2015) Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology 122(391\u2013398):e395","journal-title":"Ophthalmology"},{"key":"5702_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/OPX.0000000000001066","volume":"94","author":"JH Kim","year":"2017","unstructured":"Kim JH, Chang YS, Kim JW, Kim CG (2017) Characteristics of submacular hemorrhages in age-related macular degeneration. Optom Vis Sci 94:556\u2013563","journal-title":"Optom Vis Sci"},{"key":"5702_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ajo.2016.06.014","volume":"169","author":"JH Cho","year":"2016","unstructured":"Cho JH, Ryoo NK, Cho KH, Park SJ, Park KH, Woo SJ (2016) Incidence rate of massive submacular hemorrhage and its risk factors in polypoidal choroidal vasculopathy. Am J Ophthalmol 169:79\u201388","journal-title":"Am J Ophthalmol"},{"key":"5702_CR13","doi-asserted-by":"publisher","first-page":"14943","DOI":"10.1038\/s41598-020-72030-6","volume":"10","author":"JH Kim","year":"2020","unstructured":"Kim JH, Kim JY, Lee DW, Kim CG, Kim JW (2020) Fibrovascular pigment epithelial detachment in eyes with subretinal hemorrhage secondary to neovascular AMD or PCV: a morphologic predictor associated with poor treatment outcomes. Sci Rep 10:14943","journal-title":"Sci Rep"},{"key":"5702_CR14","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1016\/j.ophtha.2016.07.015","volume":"123","author":"M Elshout","year":"2016","unstructured":"Elshout M, van der Reis MI, de Jong-Hesse Y, Webers CA, Schouten JS (2016) Distinguishing between better and worse visual acuity by studying the correlation with quality of life in neovascular age-related macular degeneration. Ophthalmology 123:2408\u20132412","journal-title":"Ophthalmology"},{"key":"5702_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s004170050071","volume":"236","author":"J Petersen","year":"1998","unstructured":"Petersen J, Meyer-Riemann W, Ritzau-Tondrow U, Bahlmann D (1998) Visual fields after removal of subretinal hemorrhages and neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 236:241\u2013247","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5702_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/opo.12132","volume":"34","author":"AJ Gaffney","year":"2014","unstructured":"Gaffney AJ, Margrain TH, Bunce CV, Binns AM (2014) How effective is eccentric viewing training? A systematic literature review. Ophthalmic Physiol Opt 34:427\u2013437","journal-title":"Ophthalmic Physiol Opt"},{"key":"5702_CR17","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:e106-116","journal-title":"Lancet Glob Health"},{"key":"5702_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jamaophthalmol.2020.5044","volume":"139","author":"DJ Fu","year":"2021","unstructured":"Fu DJ, Keenan TD, Faes L, Lim E, Wagner SK, Moraes G, Huemer J, Kern C, Patel PJ, Balaskas K, Sim DA, Bunce C, Stratton I, Keane PA (2021) Insights from survival analyses during 12 years of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. JAMA Ophthalmol 139:57\u201367","journal-title":"JAMA Ophthalmol"},{"key":"5702_CR19","doi-asserted-by":"publisher","first-page":"e0186272","DOI":"10.1371\/journal.pone.0186272","volume":"12","author":"JH Lee","year":"2017","unstructured":"Lee JH, Lee MY, Lee WK (2017) Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation. PLoS One 12:e0186272","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"5702_CR20","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/IAE.0000000000001268","volume":"36","author":"D Su","year":"2016","unstructured":"Su D, Lin S, Phasukkijwatana N, Chen X, Tan A, Freund KB, Sarraf D (2016) An updated staging system of type 3 neovascularization using spectral domain optical coherence tomography. Retina 36(Suppl 1):S40\u2013S49","journal-title":"Retina"},{"key":"5702_CR21","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1097\/IAE.0b013e3181bfbd46","volume":"29","author":"M Engelbert","year":"2009","unstructured":"Engelbert M, Zweifel SA, Freund KB (2009) \u201dTreat and extend\u201d dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization\/retinal angiomatous proliferation. Retina 29:1424\u20131431","journal-title":"Retina"},{"key":"5702_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/08820538.2019.1701045","volume":"35","author":"JH Kim","year":"2020","unstructured":"Kim JH (2020) Results of switching from pro re nata to treat-and-extend regimen in treatment of patients with type 3 neovascularization. Semin Ophthalmol 35:33\u201340","journal-title":"Semin Ophthalmol"},{"key":"5702_CR23","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1097\/IAE.0000000000002239","volume":"39","author":"JH Kim","year":"2019","unstructured":"Kim JH, Chang YS, Kim JW, Kim CG, Lee DW, Kim HS (2019) Long-term visual changes in initially stronger fellow eyes in patients with unilateral type 3 neovascularization. Retina 39:1672\u20131681","journal-title":"Retina"},{"key":"5702_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.007","volume":"50","author":"U Schmidt-Erfurth","year":"2016","unstructured":"Schmidt-Erfurth U, Waldstein SM (2016) A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration. Prog Retin Eye Res 50:1\u201324","journal-title":"Prog Retin Eye Res"},{"key":"5702_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/IAE.0000000000003283","volume":"42","author":"V Chaudhary","year":"2022","unstructured":"Chaudhary V, Matonti F, Zarranz-Ventura J, Stewart MW (2022) The impact of fluid compartments on functional outcomes for patients with neovascular age-related macular degeneration: a systematic literature review. Retina 42:589\u2013606","journal-title":"Retina"},{"key":"5702_CR26","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1097\/IAE.0000000000000932","volume":"36","author":"JH Kim","year":"2016","unstructured":"Kim JH, Chang YS, Kim JW, Lee TG, Kim HS (2016) Diagnosis of type 3 neovascularization based on optical coherence tomography images. Retina 36:1506\u20131515","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05702-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05702-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05702-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T05:06:55Z","timestamp":1663218415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05702-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["5702"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05702-w","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"24 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The sponsor had no role in the design or conduct of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This study was approved by the Institutional Review Board of Kim\u2019s Eye Hospital (Seoul, South Korea) and was conducted in accordance with the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was not obtained since no identifying information of the participants was presented in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}